Polymers of Z α1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo

被引:133
作者
Mahadeva, R
Atkinson, C
Li, ZJ
Stewart, S
Janciauskiene, S
Kelley, DG
Parmar, J
Pitman, R
Shapiro, SD
Lomas, DA
机构
[1] Univ Cambridge, Dept Med, Div Resp Med, Cambridge CB2 1TN, England
[2] Papworth NHS Trust, Dept Histopathol, Cambridge, England
[3] Malmo Univ Hosp, Dept Med, Malmo, Sweden
[4] Washington Univ, Sch Med, Div Pulm & Crit Care, St Louis, MO USA
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA
基金
英国惠康基金;
关键词
D O I
10.1016/S0002-9440(10)62261-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The molecular mechanisms that cause emphysema are complex but most theories suggest that an excess of proteinases is a crucial requirement. This paradigm is exemplified by severe deficiency of the key antielastase within the lung: alpha(1)-antitrypsin. The Z mutant of alpha(1)-antitrypsin has a point mutation Glu342Lys in the hinge region of the molecule that renders it prone to intermolecular linkage and loop-sheet polymerization. Polymers of Z alpha(1)-antitrypsin aggregate within the liver leading to juvenile liver cirrhosis and the resultant plasma deficiency predisposes to premature emphysema. We show here that polymeric alpha(1)-antitrypsin co-localizes with neutrophils in the alveoli of individuals with Z alpha(1)-antitrypsin-related emphysema. The significance of this finding is underscored by the excess of neutrophils in these individuals and the demonstration that polymers cause an influx of neutrophils when instilled into murine lungs. Polymers exert their effect directly on neutrophils rather than via inflammatory cytokines. These data provide an explanation for the accelerated tissue destruction that is characteristic of Z alpha(1)-antitrypsin-related emphysema. The transition of native Z alpha(1)-antitrypsin to polymers inactivates its anti-proteinase function, and also converts it to a proinflammatory stimulus. These findings may also explain the progression of emphysema in some individual despite alpha(1)-antitrypsin replacement therapy.
引用
收藏
页码:377 / 386
页数:10
相关论文
共 51 条
[1]   Chronic obstructive pulmonary disease: molecular and cellular mechanisms [J].
Barnes, PJ ;
Shapiro, SD ;
Pauwels, RA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (04) :672-688
[2]  
BRANTLY M, 1988, AM J MED, V84, P13
[3]   CLINICAL-FEATURES AND HISTORY OF THE DESTRUCTIVE LUNG-DISEASE ASSOCIATED WITH ALPHA-1-ANTITRYPSIN DEFICIENCY OF ADULTS WITH PULMONARY SYMPTOMS [J].
BRANTLY, ML ;
PAUL, LD ;
MILLER, BH ;
FALK, RT ;
WU, M ;
CRYSTAL, RG .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (02) :327-336
[4]   Chronic obstructive pulmonary disease [J].
Calverley, PMA ;
Walker, P .
LANCET, 2003, 362 (9389) :1053-1061
[5]   POTENTIAL MECHANISM OF EMPHYSEMA - ALPHA-1-PROTEINASE INHIBITOR RECOVERED FROM LUNGS OF CIGARETTE SMOKERS CONTAINS OXIDIZED METHIONINE AND HAS DECREASED ELASTASE INHIBITORY CAPACITY [J].
CARP, H ;
MILLER, F ;
HOIDAL, JR ;
JANOFF, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (06) :2041-2045
[6]   Biosynthesis of alpha(1)-proteinase inhibitor by human lung-derived epithelial cells [J].
Cichy, J ;
Potempa, J ;
Travis, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8250-8255
[7]   A kinetic mechanism for the polymerization of α1-antitrypsin [J].
Dafforn, TR ;
Mahadeva, R ;
Elliott, PR ;
Sivasothy, P ;
Lomas, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9548-9555
[8]  
DUBOIS RM, 1991, BLOOD, V77, P2724
[9]   Lung polymers in Z α1-antitrypsin deficiency-related emphysema [J].
Elliott, PR ;
Bilton, D ;
Lomas, DA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 18 (05) :670-674
[10]   RISK OF CIRRHOSIS AND PRIMARY LIVER-CANCER IN ALPHA-1-ANTITRYPSIN DEFICIENCY [J].
ERIKSSON, S ;
CARLSON, J ;
VELEZ, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (12) :736-739